IM Cannabis Corp. (NasdaqCM: IMCC)
Health Care · Pharmaceuticals · CA
$1.58
-22.55% today · -97.3% 1Y
IM Cannabis Corp. (NasdaqCM: IMCC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.60M and employs 44 people.
Over the last twelve months the share price has lost 97.3%, trading between 1.55 and 77.10.
Tweenvest scores IM Cannabis Corp. across four factors: quality 38/100, value 53/100, growth 53/100. Its strongest factor is value.
IMCC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.60M
- Revenue (TTM)
- $32.25M
- P/E
- —
- EPS
- -82.28
- Dividend yield
- —
- Beta (5Y)
- 2.21
- 52-week high
- $77.10
- 52-week low
- $1.55
- Avg volume (3M)
- —
- Shares outstanding
- 1.65M
- Employees
- 44
- Next earnings
- —
About IM Cannabis Corp.
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
- ISIN
- CA44969Q4060
- Founded
- 2008
- Listed since
- May 20, 2020
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SOHM, Inc.OTCPK: SHMN | $2.81M | $0.00 | +7.78% |
| Clearmind Medicine Inc.NasdaqCM: CMND | $2.77M | $6.58 | 0.00% |
| Lasa Supergenerics LimitedNSEI: LASA | $2.77M | Rs5.32 | -5.00% |
| Nexalis Therapeutics LimitedASX: NX1 | $2.67M | AU$— | — |
| SciSparc Ltd.NasdaqCM: SPRC | $2.60M | $4.47 | -5.30% |
| XORTX Therapeutics Inc.NasdaqCM: XRTX | $2.56M | $1.41 | -17.75% |
| Welcure Drugs and Pharmaceuticals LimitedBSE: 524661 | $2.55M | Rs0.20 | -4.76% |
| Argent BioPharma LimitedASX: RGT | $2.55M | AU$0.03 | +3.33% |
Figures last refreshed Oct 11, 2026.